Initial Salvage Approaches for Relapsed/Refractory Mantle Cell Lymphoma Have Comparable Response Rates, Progression-Free and Overall Survival

被引：0
|
作者：
Caulfield, Sarah
Schlafer, Danielle
Switchenko, Jeffrey M.
Greenwell, Irl Brian
Staton, Ashley D.
Blum, Kristie A.
Grover, Natalie
Park, Steven I.
Danilov, Alexey
Epperla, Narendranath
Fenske, Timothy S.
Hamadani, Mehdi
Gordon, Max J.
Mathews, Stephanie
Valla, Kelly
Flowers, Christopher
Cohen, Jonathon B.
机构：
来源：
BLOOD | 2017年 / 130卷
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1505
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Progression-free and overall survival in patients with relapsed/refractory germ cell tumors treated with single-agent chemotherapy: Endpoints for clinical trial design
    Feldman, Darren R.
    Patil, Sujata
    Trinos, Michael J.
    Carousso, Maryann
    Ginsberg, Michelle S.
    Sheinfeld, Joel
    Bajorin, Dean F.
    Bosl, George J.
    Motzer, Robert J.
    [J]. CANCER, 2012, 118 (04) : 981 - 986
  • [42] Autologous stem cell transplantation as a first-line therapy prolongs progression-free survival in mantle cell lymphoma
    Vokurka, S.
    Koza, V.
    Jindra, P.
    Steinerova, K.
    Karas, M.
    Lysak, D.
    Svoboda, T.
    [J]. BONE MARROW TRANSPLANTATION, 2008, 41 : S247 - S248
  • [43] Similar response rates and superior early progression-free survival with gemcitabine, dexamethasone, and cisplatin salvage therapy compared with carmustine, etoposide, cytarabine, and melphalan salvage therapy prior to autologous stem cell transplantation for recurrent or refractory Hodgkin lymphoma
    Kuruvilla, J
    Nagy, T
    Pintilie, M
    Tsang, R
    Keating, A
    Crump, M
    [J]. CANCER, 2006, 106 (02) : 353 - 360
  • [44] Progression-free survival at 24 months as a landmark after autologous stem cell transplant in relapsed or refractory diffuse large B-cell lymphoma.
    Tun, Aung M.
    Maliske, Seth
    Wang, Yucai
    Maurer, Matthew J.
    Micallef, Ivana N. M.
    Inwards, David James
    Porrata, Luis F.
    Rosenthal, Allison Claire
    Kharfan-Dabaja, Mohamed
    Orme, Jacob
    Link, Brian K.
    Cerhan, James Robert
    Thompson, Carrie A.
    Habermann, Thomas Matthew
    Witzig, Thomas E.
    Ansell, Stephen M.
    Nowakowski, Grzegorz S.
    Farooq, Umar
    Johnston, Patrick B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [45] Correlation of response with progression-free (PFS) and overall (OS) survival in relapsed/refractory Ewing sarcoma (RR-ES): Results from the rEECur trial.
    Wheatley, Keith
    Kadir, Bryar
    Khan, Maria
    Fenwick, Nicola
    Gaspar, Nathalie
    Kanerva, Jukka
    Kuehne, Thomas
    Longhi, Alessandra
    Mata, Cristina
    Phillips, Marianne
    Hall, Kirsten
    Safwat, Akmal
    Morales, Claudia Valverde
    Westwood, Andrew J.
    Winstanley, Mark
    Evans, Abigail
    Strauss, Sandra J.
    Dirksen, Uta
    Whelan, Jeremy
    McCabe, Martin G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [46] Long-term progression-free survival after early autologous transplantation for mantle-cell lymphoma
    Murali, S.
    Winton, E.
    Waller, E. K.
    Heffner, L. T.
    Lonial, S.
    Flowers, C.
    Kaufman, J.
    Arellano, M.
    Lechowicz, M. J.
    Mann, K. P.
    Khoury, H. J.
    Langston, A. A.
    [J]. BONE MARROW TRANSPLANTATION, 2008, 42 (08) : 529 - 534
  • [47] Long-term progression-free survival after early autologous transplantation for mantle-cell lymphoma
    S Murali
    E Winton
    E K Waller
    L T Heffner
    S Lonial
    C Flowers
    J Kaufman
    M Arellano
    M J Lechowicz
    K P Mann
    H J Khoury
    A A Langston
    [J]. Bone Marrow Transplantation, 2008, 42 : 529 - 534
  • [48] The Impact of Clinicopathologic Factors on the Progression-Free and Overall Survival of Angioimmunoblastic T-Cell Lymphoma: A Pooled Analysis
    Haddad, Philip A.
    Powell, Frankie
    [J]. BLOOD, 2022, 140 : 12037 - 12037
  • [49] Evaluation of Overall Response Rate and Progression-Free Survival as Potential Surrogate Endpoints for Overall Survival in Immunotherapy Trials
    Mushti, Sirisha L.
    Mulkey, Flora
    Sridhara, Rajeshwari
    [J]. CLINICAL CANCER RESEARCH, 2018, 24 (10) : 2268 - 2275
  • [50] Serum free light chain reduction correlates with response and progression-free survival following carfilzomib therapy in relapsed/refractory multiple myeloma
    Vij, Ravi
    Wang, Michael
    Jagannath, Sundar
    Niesvizky, Ruben
    Jakubowiak, Andrzej J.
    Kavalerchik, Edward
    Huang, Mei
    Siegel, David S.
    [J]. LEUKEMIA & LYMPHOMA, 2015, 56 (10) : 2959 - 2961
12345